This product, the USP 35NF 30, is current from May 1, 2012 through July 31, 2012, as described below.
SIX-MONTH IMPLEMENTATION GUIDELINE
The United States PharmacopeiaNational Formulary and its supplements become official six months after being released to the public. The USPNF, which is released on November 1 of each year, becomes official on May 1 of the following year. This six-month implementation timing gives users more time to bring their methods and procedures into compliance with new and revised USPNF requirements.
The table below describes the official dates of the USPNF and its supplements. The 2010 USP 34NF 29, and its supplements, Interim Revision Announcements (IRAs) and Revision Bulletins to that edition, will be official until May 1, 2012, at which time the USP 35NF 30 becomes official.
The table below gives the details of the IRAs that will apply to USP 35NF 30.
Revision Bulletins published on the USP website become official on the date specificed in the Revision Bulletin.
NOTICE AND WARNING
Concerning U.S. Patent or Trademark RightsThe inclusion in The United States Pharmacopeia or in the National Formulary of a monograph on any drug in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner.
Concerning Use of USP or NF TextAttention is called to the fact that USP and NF text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Secretary of the USPC Board of Trustees.
Copyright © 2011 The United States Pharmacopeial Convention 12601 Twinbrook Parkway, Rockville, MD 20852
All rights reserved.
Printed in the United States by United Book Press, Inc., Baltimore, MD